KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Change in Inventory (2016 - 2025)

NovoCure (NVCR) has disclosed Change in Inventory for 12 consecutive years, with $2.0 million as the latest value for Q4 2025.

  • Quarterly Change in Inventory rose 157.76% to $2.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.7 million through Dec 2025, up 320.72% year-over-year, with the annual reading at $5.7 million for FY2025, 320.72% up from the prior year.
  • Change in Inventory hit $2.0 million in Q4 2025 for NovoCure, up from -$886000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $4.8 million in Q1 2022 to a low of -$3.8 million in Q3 2021.
  • Historically, Change in Inventory has averaged $693900.0 across 5 years, with a median of $982500.0 in 2021.
  • Biggest five-year swings in Change in Inventory: tumbled 7041.82% in 2021 and later soared 594.74% in 2023.
  • Year by year, Change in Inventory stood at $1.7 million in 2021, then skyrocketed by 34.02% to $2.3 million in 2022, then plummeted by 70.67% to $669000.0 in 2023, then plummeted by 613.45% to -$3.4 million in 2024, then surged by 157.76% to $2.0 million in 2025.
  • Business Quant data shows Change in Inventory for NVCR at $2.0 million in Q4 2025, -$886000.0 in Q3 2025, and $629000.0 in Q2 2025.